Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)
Clinical trial NCT05859724 · TERMINATED
Trial details
- NCT number
- NCT05859724
- Sponsor
- Yellow Jersey Therapeutics AG
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-10
- Primary completion
- 2024-10-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.